There is a version of this that happens at two in the morning.
A man who has been managing a slow stream for six years, who has told himself for all six of them that it is just what happens, stands in a bathroom and cannot go. Not slowly. Not eventually. At all. An hour later he is in an emergency room being catheterised by someone he has never met.
Every man who has been near that night reorganises his priorities afterward. And the question he asks on the drive home is always the same one: was there any way to know that was coming?
There was. There are two measurements that carry real predictive weight for exactly that event. One of them is a number in millimetres that almost nobody orders. The other one is not in his pelvis at all.
What men get wrong
The belief is that retention is random — a bolt from nowhere, or alternatively the inevitable end of the road once the gland gets big enough. Both versions put the man in the passenger seat, which is why both are comfortable.
And the gland-size version is the one most men are running, because size is the only number anybody ever gave them. I have made the case elsewhere that the volume figure in your file explains very little about how you actually feel — that argument is here, with the four studies behind it, and I am not going to re-run it.
What I want to do instead is answer the harder question. If size does not predict the symptoms, and it does not predict the emergency either, then what does?
Measurement one: the shape of the outlet
It has a name, and the name is the whole point, because you cannot ask for something you cannot say.
Intravesical prostatic protrusion. IPP. It is the distance the gland bulges into the bladder — measured, as a 2018 review in Current Urology puts it, as the vertical distance from the tip of the protrusion to the circumference of the bladder at the bladder neck. Millimetres, not grams. Direction, not bulk.
It gets graded in three bands: under 5 mm, 5 to 10 mm, and over 10 mm.
Here is why that matters. In the pressure-flow data that review cites, among men in the first two grades — protrusion under 10 mm — roughly 21% were obstructed. Among the men above 10 mm, it was 96%.
Read those two numbers next to each other again. Same organ. Same disease name on the chart. One in five versus nineteen in twenty.
That is what a useful measurement looks like, and about one man in ten between 40 and 79 is carrying severe protrusion right now without knowing the term exists.
Now the honest part, because a number this clean deserves scrutiny rather than applause. The exact threshold is disputed. The 10 mm figure performs well in that review — high sensitivity and specificity on transabdominal ultrasound. But an independent Korean series of 239 men who underwent full pressure-flow studies put the discriminating line much lower, at 5.5 mm, and reported sensitivity around 67% and specificity around 80% — considerably weaker. Two groups, two cut-offs, two levels of confidence.
So the direction is solid and the dividing line is not settled. That is a real limitation and you should know it before you walk into an appointment quoting a number at anybody.
One more thing, and it is not optional: you cannot measure this yourself. It requires ultrasound — transabdominal will do it, transrectal does it better. There is no home version, no symptom that stands in for it, and nothing on the internet that lets you estimate it. The action here is to ask, not to guess.
Measurement two: what your whole body has in reserve
This is the part that will sound like a non sequitur for about thirty seconds.
On 23 September 2026, a group at the Affiliated Hospital of Guizhou Medical University published a study in Frontiers in Endocrinology looking at 328 men who had both an enlarged prostate and sarcopenia — clinically significant loss of skeletal muscle mass. They asked which factors predicted acute urinary retention.
After statistical weighting to balance the groups, lower skeletal muscle index was independently associated with retention. Not as a bystander. As one of six retained predictors.
Two factors raised risk: older age, and a previous episode of catheterisation. Three lowered it: higher muscle mass, and both of the common prescription classes men take for this — 5-alpha-reductase inhibitors and alpha-blockers. The model’s ability to separate the men who had an event from the men who did not came out at an AUC of 0.789, with a confidence interval running from 0.734 to 0.838.
And the relationship was not a straight line. Risk did not climb gently as muscle fell. It was flat and then it bent — the test for non-linearity came back at p = 0.002 — with risk escalating sharply once muscle mass dropped past a point.
I am deliberately not giving you that point as a number. The inflection was calculated in a cohort of Chinese men against an Asian population standard for muscle mass, and body composition reference ranges are population-specific. It is not your cutoff and it would be irresponsible to hand it to you as one. What transfers is the shape of the finding: below a certain reserve, this stops being gradual.
The best thing in that paper is in its limitations section
Nobody reads the limitations section. That is where this story was sitting.
The authors write that detailed urological parameters — intravesical prostatic protrusion, post-void residual, PSA, peak flow — “were not uniformly available in our retrospective dataset and were consequently omitted from the models.”
Sit with that. A team builds a predictive model for urinary retention, and the measurements it could not get hold of include the one with a 21-versus-96 obstruction gradient attached to it.
They named the better predictor on their way past it.
Which tells you something about the state of ordinary care, not about the quality of the researchers. Those four numbers were missing from a hospital’s own records because they are not routinely captured. Yours are probably missing too.
What is actually happening in there
The mechanics are not mysterious once you have both measurements in hand.
A gland protruding into the bladder neck sits over the outlet like a ball-valve seating itself. That raises resistance. Your bladder is a muscle, and a muscle facing resistance does what muscles do — it compensates. The wall thickens. It generates more pressure. It gets the job done.
And you experience that as nothing much. A slower stream. A pause before it starts. You file it under getting older, because it is not painful and it is not dramatic, and for years you are right that it is manageable.
Compensation is not health. It is a muscle working overtime, and overtime is paid for out of reserve.
Meanwhile the other side erodes the account. Muscle loss travels with insulin resistance — that study retained a triglyceride-glucose index among its candidate features, though it did not reach significance in the final model. Insulin resistance travels with worse small-vessel function. And a bladder wall with poorer perfusion is a bladder wall with less to give on the day it is asked for everything. That creates biological drag.
So retention is not the start of the problem. It is the day the compensation runs out. The body had been sending notices for years; that night the invoice came due.
This is the whole argument in one line: the prostate is not failing in isolation. Here that is not a slogan. It is a regression output.
Why men misread this
Four reasons, and none of them are stupidity.
Every appointment he has ever had named exactly one organ, so he built a one-organ model of himself. Size is intuitive and millimetres of protrusion are not — nobody has ever described a prostate to him as a direction. Retention reached him as a story about somebody’s brother-in-law rather than as a rate, so it is either terrifying or dismissible and never simply his risk. And nobody ever drew him a line from his legs to his bladder.
Now let me size this honestly, because I am not in the business of frightening men into buying things.
In a Danish national registry following 70,775 men aged 45 and over across two decades, acute urinary retention ran at roughly three events per 1,000 man-years. It is uncommon. Most men reading this will never have one. Which is precisely why the men who are carrying the risk markers deserve to know they are carrying them — the population rate is not your rate.
And one figure from that registry, once, because it explains what reserve actually means: the men who had a retention event carried meaningfully higher mortality over the following year than the general population did. Not because a bladder killed them. Because needing a catheter at two in the morning is what low physiological reserve looks like when it finally announces itself out loud.
Then the counterweight, which is genuinely good news. Across those same two decades, the proportion of men who went on to prostate surgery after a retention event fell substantially. Retention is increasingly a managed event rather than an automatic operation.
And the limits of the muscle study, stated plainly: 328 men, one hospital, retrospective, and every man in it already had sarcopenia. That means it sorts risk inside an already-high-risk group — it cannot tell you what happens to a man who is not losing muscle. The model was validated internally only, with no second cohort. This is an association worth acting on. It is not a demonstrated cause, and anyone presenting it as one is selling something.
What to do with this
1. Ask for the measurement by name. Write it down before you go: intravesical prostatic protrusion — can we measure it? If the answer is that it is not routinely done, ask whether it can be, and ask what your post-void residual and peak flow are while you are there. Those are three of the four numbers that went missing from a hospital’s own dataset.
2. Get the metabolic picture. Fasting glucose and triglycerides, at minimum. Muscle loss and insulin resistance arrive together and reinforce each other.
3. Defend lean mass on purpose, because it is the only variable in that model you control. Resistance training two to three times a week, weighted and progressive, with the emphasis on legs and back — that is where most of your mass lives. Protein at every meal rather than all of it at seven in the evening, which is what most men in this bracket are doing. Walk ten to fifteen minutes after your largest meal. Muscle is metabolic insurance.
4. Eat for the vascular side. Eggs, fish, lean red meat, Greek yogurt and lentils to hold the protein floor. Nitrate-rich greens — arugula, beet tops, spinach. Cooked tomatoes with olive oil. Dark berries. This is nutritional support for a system, not treatment for a condition.
5. Lower the nightly load. Move fluid earlier in the day and taper over the last two or three hours. Cut late alcohol and late salt. Do not sit on a full bladder for hours because a meeting is running long. And read the label on over-the-counter decongestants and antihistamines — several of them tighten the outlet, and more than one man’s first retention episode arrived in cold season.
6. Sleep seven to nine hours with a consistent wake time. The muscle you trained on Tuesday is built on Tuesday night or not at all.
7. Do not stop prescribed medication over an article. In that model both drug classes men take for this were associated with lower retention risk. Ask your doctor questions. Do not quit on your own.
8. If you have ever had an episode where you could not urinate and needed help — that was the single loudest factor in the entire model. Not a story to tell at a barbecue. A data point about you. Treat it accordingly.
The close
Stop asking how big it is. That question has never once told you what to do.
Ask how far it protrudes. Ask what your residual is. Then go build the reserve, because that half is yours and nobody is going to hand it to you — no bottle, no shortcut, no number on a chart.
The gland is not the measurement. One measurement is the shape of the outlet. The other is your whole-body reserve, and it is measured nowhere near your pelvis.
Write the name down before your next appointment. Then go pick something heavy up, three times a week. Stop with the excuses.
Let’s get healthy.
If you want the urinary side laid out plainly before that appointment — what to ask for, what to eat, and how to read your own symptoms instead of guessing at them: Get the free prostate & urinary guide
This article is for informational and educational purposes only. It is not medical advice and is not intended to diagnose, treat, cure or prevent any disease. Acute urinary retention is a medical emergency — if you cannot pass urine, seek care immediately. If you have a diagnosed condition or take prescription medication, speak with your doctor before changing your diet, your training or your routine.
The studies this is built on
Yang Q, Xu Y, Hou S, Yang B, Huang L. “Association between skeletal muscle mass and acute urinary retention in patients with benign prostatic hyperplasia and sarcopenia.” Frontiers in Endocrinology, 2026;17:1965871. Published 23 September 2026.
Gandhi J, Weissbart SJ, Kim AN, et al. “Clinical considerations for intravesical prostatic protrusion in the evaluation and management of bladder outlet obstruction secondary to benign prostatic hyperplasia.” Current Urology, 2018;12(1):6–12.
Shin SH, Kim JW, Kim JW, Oh MM, Moon DG. “Defining the degree of intravesical prostatic protrusion in association with bladder outlet obstruction.” Korean Journal of Urology, 2013;54(6):369–372.
Bengtsen MB, Heide-Jørgensen U, Borre M, Knudsen JS, Nørgaard M. “Acute urinary retention in Danish men: a 21-year nationwide cohort study of incidence, treatment and mortality.” The Prostate, 2023;83:87–96.